The Influence of Pharmaceutical Industry on Asthma Guidelines

Recent changes in international asthma guidelines may be influenced by pharmaceutical industry conflicts of interest. Most randomized controlled trials of SMART use butesinine for motorol, which is marketed by AstraZeneca with over $2.5 billion in sales worldwide in 2021. In mild asthma, four of the five studies in a recent Cochrane review were funded by AstRAZeneca. Some authors were employees of Astra Zenec and other authors received personal payments.